Richard Zall (Rick)

• Represented Diana Health in its $55.0 million Series C preferred stock financing, including participation from new investor HealthQuest Capital and existing investors Norwest Venture Partners, Point 406 Ventures, LRVHealth, and AlleyCorp Partners, and handled all legal aspects of the transaction including negotiation of definitive agreements.
• Represented Lehigh Valley Health Network, a 14-hospital health system in Pennsylvania, in its strategic combination with Jefferson Health, one of the top healthcare systems in the country and the largest provider in the Philadelphia area.
• Represented Medical Home Network, a national value based care management company, in its sale of substantially all of its assets to an affiliate of Oak HC/FT in exchange for cash and equity, including the transfer of Care Innovations, LLC and other operating assets, and ongoing post-closing restructuring matters, resulting in Medical Home Network’s transition to a charitable foundation.
• Represented PM Pediatrics, a nationally recognized pediatric urgent care organization with operations in 7 states, in connection with the formation of a joint venture with RWJ Barnabas to operate PMP’s New Jersey business operations.
• Represented Accuity Delivery Systems in its sale to an affiliate of private equity firm, Frazier Healthcare Partners.
• Represented Apnicure, a healthcare technology and medical device company, in connection with regulatory compliance state telemedicine laws and corporate structuring.
• Represented Archimedes Health Investors and its portfolio company, National Partners in Health, in connection with the acquisition of Waxahachie Anaesthesia Consultants, National Medical Billing Management, Anaesthesia Resources, and TAMI and their related physician billing and practice management companies.
• Represented Ares Management LLC, as special healthcare counsel in its acquisitions of both OB Hospitalist Group and Unified Physician Management.
• Represented Ascension Health and it’s Our Lady of Lourdes Memorial Hospital in Binghamton, New York in its sale to The Guthrie Clinic.
• Represented Bain Capital Ventures in its investment in Strategic Pharmaceutical Solutions, d/b/a Vetsource, an institutional pharmacy that dispenses prescription products to veterinarians and animal hospitals.
• Represented The Brooklyn Hospital Center in the establishment of ModernMD, an urgent care joint venture with Blue Wolf Capital.
• Represented Cambia Health in the establishment of a joint venture platform for Cambia (Regence Blue Cross) and Blue Cross/Blue Shield of North Carolina.
• Represented Cincinnati Eye Institute (CEI) in the launch of CEI Vision Partners, a new management services organization formed with an investment from Revelstoke Capital Partners.
• Represented Concerto Healthcare in the sale of its affiliated health plan in Michigan to Centene, a publicly traded HMO.
• Represented Crystal Run Healthcare in the structuring of an ambulatory surgery joint venture with Orange Regional Medical Center.
• Represented Data Driven Delivery Systems, LLC in its sale to Blue Cross Blue Shield of Michigan.
• Represented Diana Health, a women’s health services company, in its $34.0 million Series B funding round led by Norwest Venture Partners with participation by .406 Ventures, LRV Health, and AlleyCorp.
• Represented Eleanor Health, an outpatient addiction treatment provider, in its $50.0 million Series C financing, and $30.0 million Series D financing, led by General Catalyst with participation by Town Hall Ventures, Echo Health Ventures, Northpond Ventures, Rethink Impact and Emerson Collective.
• Represented Healthcare Payment Specialists in their sale to acquirer, Nautic Partners Health Connect in establishing a joint venture between Newport Heath Solutions and Northwell Health to commercialize NHS’ population health management software.
• Represented Helena Special Investments as corporate and regulatory counsel which led a $100.0 million Series A investment in Lykos Therapeutics, provider of MDMA-assisted therapy for PTSD. This transaction was challenging since Lykos is a subsidiary of Multidisciplinary Association for Psychedelic Studies (MAPS), a not-for-profit research institution.
• Represented Jersey City Medical Center in its sale to Robert Wood Johnson/Barnabas Health System.
• Represented Kayne Anderson Capital Advisors in connection with the New Jersey Department of Health for the change of ownership of an assisted living residence in New Jersey as a liaison between the client and the regulators.
• Represented Kelsey-Seybold Medical Group in its sale to TPG Capital of a minority interest in its management services company.
• Represented Kode Health, a tech-enabled medical coding company, in its $22.5 million Series B financing led by Noro-Moseley Partners with participation by FCA Venture Partners and Epsilon Healthcare Investors.
• Represented Lehigh Valley Health Network in its merger with Jefferson Health creating a $14.0 billion integrated health delivery system in Eastern Pennsylvania.
• Represented Medical Home Network in connection with counseling on a myriad of U.S. laws, state and federal Stark and anti-kickback laws, regulating healthcare payment and delivery systems, and best practices for distributing shared savings.
• Represented Medical Home Network in the investment by Oak HC/FT.
• Represented MEP Health, a Maryland-based physician emergency medicine group, in its merger with U.S. Acute Care Solutions.
• Represented Mount Sinai Health System in its joint ventures with The Children's Hospital of Philadelphia (CHOP) and National Jewish Health.
• Represented North Haven Credit Partners in connection with an investment and loan to Code 3, free standing emergency room centers in Texas and Nevada.
• Represented Northern Westchester Hospital in its strategic health system affiliation with Northwell Health.
• Represented Richmond University Medical Center in its acquisition of St. Vincent’s Staten Island Hospital, and sale of its interest in The Heart Institute to Staten Island University Hospital.
• Represented Sentinel Capital Partners in their investment in MB2 Dental Solutions, a dental service organization with 85 affiliated practices.
• Represented Sephardic Nursing and Rehabilitation Center in its sale to Allure, Inc. Solera Capital in the sale of its portfolio company The Little Clinic to the retailer Kroger, Inc.
• Represented South Nassau Communities Hospital in its acquisition of Long Beach Medical Center.
• Represented St. Luke’s-Roosevelt Hospital Center, Inc. in the spin-off of its outpatient primary care clinics to an affiliate of William F. Ryan Community Health Center, Inc.
• Represented Teladoc, Inc., in connection with state licensing and regulatory compliance matters.
• Represented Town Hall Ventures in its co-investment in VillageMD.
• Represented Virginia Eye Consultants in its sale to CEI Vision Partners.
• Represented WellBox, Inc. in its establishment of a Medicare chronic care management (CCM).

Rick advises clients across the healthcare industry on high stakes transactions and regulatory matters, including mergers and acquisitions, joint ventures, financings, and complex commercial arrangements. He works closely with healthcare operators, private equity sponsors, and lenders to align deal strategy with evolving regulatory requirements, helping clients mitigate risk and achieve efficient, successful outcomes.

Rick leads the firm’s global healthcare transactional and regulatory practice, one of the nation’s leading healthcare teams providing integrated transactional and regulatory counsel. He advises clients on deal structuring, diligence, regulatory risk assessment, and governmental approvals across a broad range of healthcare transactions.

Widely regarded as a leader in healthcare law, Rick has been ranked in Band 1 by Chambers USA for more than two decades and was named a Law360 Healthcare MVP in 2025. In the 2026 Chambers USA guide, clients praised him as “an incredible talent with a great legal mind and practical approach,” noting his ability to quickly understand business priorities, tailor advice to operational realities, and identify commercial implications alongside legal risks.

Rick’s regulatory experience includes healthcare fraud and abuse laws, corporate practice of medicine requirements, physician compensation and incentive arrangements, and Medicare and Medicaid reimbursement issues. He also advises on value-based care models, telemedicine, and other emerging healthcare delivery and digital health structures.

Known for his practical, business-focused approach, Rick helps clients identify regulatory challenges early, integrate compliance considerations into transaction planning, and navigate complex legal requirements without losing sight of commercial objectives. His experience enables clients to address regulatory uncertainty efficiently, streamline negotiations, and execute strategic initiatives in a highly regulated industry.

Rick also serves as Secretary of the Board of Directors of the Clinton Health Access Initiative (CHAI), a global health organization founded and chaired by former President Bill Clinton. He has served as outside general counsel to CHAI since its founding in 2010, providing governance and corporate legal advice in support of the organization’s mission.